Log In
Print
BCIQ
Print
Print this Print this
 

Flolan, epoprostenol

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionProstacyclin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation

Partner

Gilead Sciences Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today